Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Tran

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
Nature Communications|February 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, et al.
The Journal of Clinical Investigation|February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancersParisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
Cancer Immunology Research|February 3, 2019
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal CancerWinifred Lo, Maria Parkhurst, Paul F Robbins, et al.
Oncoimmunology|April 2, 2021
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancerAndrew J Gunderson, Venkatesh Rajamanickam, Cynthia Bui, et al.
Respiratory Research|August 2, 2022
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19Jeanne-Marie Perotin, Fabien Gierski, Lois Bolko, et al.
JCI Insight|January 23, 2025
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patientsXiongfei Xu, Shiwei Guo, Haihui Gu, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
The Journal of Clinical Investigation|October 15, 2019
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytesAlena Gros, Eric Tran, Maria R Parkhurst, et al.
Plos One|October 17, 2008
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancerKaty Milne, Rebecca O Barnes, Adam Girardin, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Investigation|March 27, 2014
PD-1 identifies the patient-specific CD8⁺ tumor-reactive repertoire infiltrating human tumorsAlena Gros, Paul F Robbins, Xin Yao, et al.
Nature Communications|February 17, 2021
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsRebekka Duhen, Carmen Ballesteros-Merino, Alexandra K Frye, et al.
The Journal of Clinical Investigation|February 5, 2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancersParisa Malekzadeh, Anna Pasetto, Paul F Robbins, et al.
Cancer Immunology Research|February 3, 2019
Immunologic Recognition of a Shared p53 Mutated Neoantigen in a Patient with Metastatic Colorectal CancerWinifred Lo, Maria Parkhurst, Paul F Robbins, et al.
Oncoimmunology|April 2, 2021
Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancerAndrew J Gunderson, Venkatesh Rajamanickam, Cynthia Bui, et al.
Respiratory Research|August 2, 2022
Cluster analysis unveils a severe persistent respiratory impairment phenotype 3-months after severe COVID-19Jeanne-Marie Perotin, Fabien Gierski, Lois Bolko, et al.
JCI Insight|January 23, 2025
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patientsXiongfei Xu, Shiwei Guo, Haihui Gu, et al.
Nature Cancer|December 20, 2021
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor typesJared J Gartner, Maria R Parkhurst, Alena Gros, et al.
The Journal of Clinical Investigation|October 15, 2019
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytesAlena Gros, Eric Tran, Maria R Parkhurst, et al.
Plos One|October 17, 2008
Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancerKaty Milne, Rebecca O Barnes, Adam Girardin, et al.
Pageof 13